Do Analysts Expect Sana Biotechnology Inc (SANA) Stock to Rise After It Has Gained 58.85% in a Month?

Analysts who follow Sana Biotechnology Inc (SANA) on average expect it to increase 8.36% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. That average rating earns the stock an Analyst Ranking of 48, which means it ranks higher than 48 of stocks, based on data compiled by InvestorsObserver.

Wall Street analysts are rating SANA a Strong Buy today. Find out what this means to you and get the rest of the rankings on SANA!

See Full SANA Report

Why are Analyst Ratings Important?

Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected. InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.

What's Happening With Sana Biotechnology Inc Stock Today?

Sana Biotechnology Inc (SANA) stock has gained 1.15% while the S&P 500 is down -0.02% as of 11:46 AM on Friday, Mar 8. SANA is up $0.11 from the previous closing price of $9.58 on volume of 513,638 shares. Over the past year the S&P 500 has gained 31.60% while SANA is up 190.12%. SANA lost -$1.46 per share the over the last 12 months. Click Here to get the full Stock Report for Sana Biotechnology Inc stock.